Opaleye Management Inc. 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | Opaleye Management Inc. | 3,171,800 4.940% | 171,400 (+5.71%) | Filing |
| 2020-09-18 6:48 pm Purchase | 2020-09-09 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | Opaleye Management Inc. | 3,000,400 5.100% | 3,000,400 (New Position) | Filing |